Radical prostatectomy improves progression‐free and cancer‐specific survival in men with lymph node positive prostate cancer in the prostate‐specific antigen era: a confirmatory study

Study Type – Therapy (outcomes research)
Level of Evidence 2b

[1]  Y. Kaiho,et al.  [Radical retropubic prostatectomy]. , 2002, Nihon rinsho. Japanese journal of clinical medicine.

[2]  J. Gschwend,et al.  Survival benefit of radical prostatectomy in lymph node-positive patients with prostate cancer. , 2010, European urology.

[3]  A. Haese*,et al.  Current technique of open intrafascial nerve-sparing retropubic prostatectomy. , 2009, European urology.

[4]  F. Fazio,et al.  Long-term follow-up of patients with prostate cancer and nodal metastases treated by pelvic lymphadenectomy and radical prostatectomy: the positive impact of adjuvant radiotherapy. , 2009, European urology.

[5]  Michel Bolla,et al.  [EAU guidelines on prostate cancer]. , 2009, Actas urologicas espanolas.

[6]  F. Burkhard,et al.  Good outcome for patients with few lymph node metastases after radical retropubic prostatectomy. , 2008, European urology.

[7]  C. Roehrborn,et al.  Comparison of stage migration patterns between Europe and the USA: an analysis of 11 350 men treated with radical prostatectomy for prostate cancer , 2008, BJU international.

[8]  U. Studer,et al.  The template of the primary lymphatic landing sites of the prostate should be revisited: results of a multimodality mapping study. , 2008, European urology.

[9]  E. Bergstralh,et al.  Long-term outcome after radical prostatectomy for patients with lymph node positive prostate cancer in the prostate specific antigen era. , 2007, The Journal of urology.

[10]  S. Rafii,et al.  Preparing the "soil": the premetastatic niche. , 2006, Cancer research.

[11]  Jorge Yao,et al.  Immediate versus deferred androgen deprivation treatment in patients with node-positive prostate cancer after radical prostatectomy and pelvic lymphadenectomy. , 2006, The Lancet. Oncology.

[12]  M. Graefen,et al.  Open retropubic nerve-sparing radical prostatectomy. , 2006, European urology.

[13]  F. Burkhard,et al.  Disease progression and survival of patients with positive lymph nodes after radical prostatectomy. Is there a chance of cure? , 2003, The Journal of urology.

[14]  M. Graefen,et al.  Intraoperative and perioperative morbidity of contemporary radical retropubic prostatectomy in a consecutive series of 1243 patients: results of a single center between 1999 and 2002. , 2003, European urology.

[15]  M. Grimm,et al.  Clinical outcome of patients with lymph node positive prostate cancer after radical prostatectomy versus androgen deprivation. , 2002, European urology.

[16]  E. Trimble,et al.  Survival Effect of Maximal Cytoreductive Surgery for Advanced Ovarian Carcinoma During the Platinum Era: A Meta-Analysis. , 2023, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  J. Molinuevo,et al.  Bilateral subthalamic stimulation monotherapy in advanced Parkinson's disease: Long‐term follow‐up of patients , 2002, Movement disorders : official journal of the Movement Disorder Society.

[18]  C. Compton,et al.  AJCC Cancer Staging Manual , 2002, Springer New York.

[19]  R. Sylvester,et al.  Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial , 2001, The Lancet.

[20]  E. Bergstralh,et al.  Radical retropubic prostatectomy plus orchiectomy versus orchiectomy alone for pTxN+ prostate cancer: a matched comparison. , 1999, The Journal of urology.

[21]  J. Cadeddu,et al.  Stage D1 (T1-3, N1-3, M0) prostate cancer: a case-controlled comparison of conservative treatment versus radical prostatectomy. , 1997, Urology.

[22]  N. Schmeller,et al.  Early endocrine therapy versus radical prostatectomy combined with early endocrine therapy for stage D1 prostate cancer. , 1997, British journal of urology.

[23]  P. Schellhammer,et al.  Results of radical prostatectomy in men with locally advanced prostate cancer: multi-institutional pooled analysis. , 1997, European urology.

[24]  D. Fryback,et al.  The impact of co-morbidity on life expectancy among men with localized prostate cancer. , 1996, The Journal of urology.

[25]  J. Hugosson,et al.  Need for hospital care and palliative treatment for prostate cancer treated with noncurative intent. , 1995, The Journal of urology.

[26]  F. Marshall.  Radical nephrectomy. , 1995, Urology.

[27]  T. Stamey,et al.  Zonal Distribution of Prostatic Adenocarcinoma: Correlation with Histologic Pattern and Direction of Spread , 1988, The American journal of surgical pathology.